Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Natco Pharma Ltd. Share Issue/Capital Change 2021

Nov 22, 2021

62741_rns_2021-11-22_061d781d-17d9-4cc7-a5c0-ba393c38472e.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [451 x 46] intentionally omitted <==

November 22, 2021

The Manager DCS-LISTING M/s. BSE Ltd Phiroze Jeejeebhoy Towers Dalal Street, Mumbai 400 001

Manager – Listing M/s. National Stock Exchange of India Ltd “Exchange Plaza”, Bandra – Kurla Complex Bandra (E) Mumbai -400 051

Scrip Code: 524816

Scrip Code: NATCOPHARM

Dear Sir/Madam,

Sub: Information regarding issue of duplicate share certificate(s) under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

With reference to the above captioned subject, we are in process of issuing duplicate share certificates in the following cases in lieu of the originals thereof, stated to have been lost by the respective shareholder:

S No. Folio No. Name Shares Certificate Nos
1 52018 NILANJAN SEN 100 5930
2 45662 ARUNA K GUPTA 100 8383

This is for your information and record.

Thanking you

Yours faithfully

For NATCO Pharma Limited

ADINARAYANA MADINEEDI Digitally signed by ADINARAYANA MADINEEDI DN: c=IN, st=Telangana, 2.5.4.20=a008497813275d4124d2b42c9f7f924b5b96346aa8741a90d57d102d95c690c8, postalCode=500017, street=12-13-266 street no 2 Lane no 9 Tarnaka secunderabad, pseudonym=52398da71daa6f1de479ec9618474b70, serialNumber=3da487f04b8912870dea3f277d9e87fc06da96e80b36d2beb1428dfe3f665de7, o=Personal, cn=ADINARAYANA MADINEEDI Date: 2021.11.22 16:33:43 +05'30'

M. Adinarayana Company Secretary & Vice President (Legal & Corp Affairs)